Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

30 juin 2026 01h30 HE | Source: Vect-Horus

Vect-Horus announces collaboration and license option agreement with Servier to develop targeted oligonucleotide therapeutics for rare CNS diseases

Vect-Horus announces a research evaluation and exclusive license option agreement with Servier.
30 juin 2026 01h30 HE | Source: Vect-Horus

Vect-Horus conclut un accord de collaboration et d’option de licence avec Servier afin de déveloper des traitements ciblés à base d'oligonucléotides pour les maladies rares du système nerveux central

Vect-Horus annonce la conclusion d'un accord portant sur une collaboration de recherche et une option de licence exclusive avec Servier.
23 juin 2026 09h00 HE | Source: NeOnc Technologies Holdings, Inc.

NeOnc Technologies Receives UAE IND Approval for NEO100, Expanding Global Development Ahead of Anticipated Phase 2 Data Milestone

NeOnc Technologies Receives UAE IND Approval for NEO100, Expanding Global Development Ahead of Anticipated Phase 2 Data Milestone
16 juin 2026 10h50 HE | Source: Verified Market Research

Hydrogels for Medical Application Market to Reach USD 2.93 Billion by 2033, Expanding at 9.2% CAGR Driven by Advanced Wound Care Demand, Controlled Drug Delivery Innovation, and Tissue Engineering Breakthroughs – Verified Market Research

Lewes, Delaware, June 16, 2026 (GLOBE NEWSWIRE) -- Verified Market Research® has released its latest intelligence report on the Hydrogels for Medical Application Market, confirming that this dynamic...
29 mai 2026 09h05 HE | Source: 24/7 Market News and NeOnc Technology

The Next Great AI Revolution May Be Drug Delivery

NeOnc (NASDAQ:NTHI) is developing therapies and delivery technologies targeting aggressive brain cancers and CNS-related conditions, and could be part of t
26 mai 2026 09h32 HE | Source: Research and Markets

Drug Eluting Stent Market Size, Share & Trends Analysis Report 2026-2033

Dublin, May 26, 2026 (GLOBE NEWSWIRE) -- The "Drug Eluting Stent Market Size, Share & Trends Analysis Report by Type of Coating, End Use, Region, and Growth Forecasts, 2026-2033" has been added...
12 mai 2026 08h40 HE | Source: Fortis Life Sciences

Fortis Life Sciences Awards 2026 AbNano® VHH Discovery Grant to Deliver Biosciences for Targeted Drug Delivery Research

Fortis Life Sciences awards Deliver Biosciences the 2026 AbNano® VHH Discovery Grant for in vivo CAR-T, gene therapy & nanoparticle drug delivery research
07 mai 2026 05h24 HE | Source: Research and Markets

Drug/Device and Device/Drug Combination Products EU and FDA Regulations and Frameworks Training Course (ONLINE EVENT: Sept 14th - Sept 15th, 2026)

Dublin, May 07, 2026 (GLOBE NEWSWIRE) -- The "Navigating EU and FDA Regulations for Drug/Device and Device/Drug Combination Products (Sept 14th - Sept 15th, 2026)" training has been added to ...
06 mai 2026 11h40 HE | Source: Research and Markets

Navigating EU (European Union) and FDA (Food and Drug Administration) Regulations for Drug/Device and Device/Drug Combination Products Training Course (ONLINE EVENT: Sept 14th - Sept 15th, 2026)

Dublin, May 06, 2026 (GLOBE NEWSWIRE) -- The "Navigating EU (European Union) and FDA (Food and Drug Administration) Regulations for Drug/Device and Device/Drug Combination Products Training Course...
06 mai 2026 11h04 HE | Source: Research and Markets

Technology Transfer for Solid Dosage Forms Introduction Course: Gain a Foundational Understanding Blending Theoretical Insights with Practical Applications (ONLINE EVENT: Sept 18, 2026)

Dublin, May 06, 2026 (GLOBE NEWSWIRE) -- The "An Introduction to Technology Transfer for Solid Dosage Forms (Sept 18, 2026)" training has been added to ResearchAndMarkets.com's offering.This course...

Page suivante